These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14615455)

  • 21. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?
    Sayer R; Paul J; Tuke PW; Hargreaves S; Noursadeghi M; Tedder RS; Grant P; Edwards SG; Miller RF
    Int J STD AIDS; 2011 Oct; 22(10):585-9. PubMed ID: 21998180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
    Cathomas G
    Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
    Schulz TF; Cesarman E
    Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaline vascular Castleman's disease: a case report and brief review of the literature.
    van den Berge M; Pauwels P; Jakimowicz JJ; Creemers GJ
    Neth J Med; 2002 Dec; 60(11):444-7. PubMed ID: 12685494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
    Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
    Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of human interleukin-6 in systemic manifestations of human herpesvirus type 8-associated multicentric Castleman's disease.
    Foussat A; Fior R; Girard T; Boue F; Wijdenes J; Galanaud P; Emilie D
    AIDS; 1999 Jan; 13(1):150-2. PubMed ID: 10207568
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.
    Bower M; Newsom-Davis T; Naresh K; Merchant S; Lee B; Gazzard B; Stebbing J; Nelson M
    J Clin Oncol; 2011 Jun; 29(18):2481-6. PubMed ID: 21555697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient.
    Dupin N; Krivine A; Calvez V; Gorin I; Franck N; Escande JP
    AIDS; 1997 Sep; 11(11):1400-1. PubMed ID: 9302455
    [No Abstract]   [Full Text] [Related]  

  • 30. An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS.
    Zietz C; Bogner JR; Goebel FD; Löhrs U
    N Engl J Med; 1999 Jun; 340(24):1923-4. PubMed ID: 10375310
    [No Abstract]   [Full Text] [Related]  

  • 31. [HHV-8: certainties and mysteries].
    Dupin N
    Rev Prat; 2003 Jun; 53(12):1285-8. PubMed ID: 12920934
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasmablastic microlymphoma occurring in human herpesvirus 8 (HHV-8)-positive multicentric Castleman's disease and featuring a follicular growth pattern.
    Dargent JL; Lespagnard L; Sirtaine N; Cantinieaux B; Li R; Hermans P
    APMIS; 2007 Jul; 115(7):869-74. PubMed ID: 17614857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
    van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
    Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fulminant HHV-8 associated Castleman's disease in a non-HIV, Kaposi sarcoma patient with borderline hemophagocytic syndrome.
    Barbarov I; Koren-Michowitz M; Schiby G; Portnoy O; Livingstone D; Segal G
    Isr Med Assoc J; 2015 Apr; 17(4):253-5. PubMed ID: 26040056
    [No Abstract]   [Full Text] [Related]  

  • 35. Multicentric Castleman's disease in a patient with HIV.
    Fowler A; Collins L; de Ruiter A; Whittaker S; Kulasegaram R; Bradbeer C
    Int J STD AIDS; 2006 Jan; 17(1):63-4. PubMed ID: 16409683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicentric Castleman's disease masquerading as HIV-related lymphoma.
    Dayyani F; Pantanowitz L; Sandridge TG; Sullivan RJ; Dezube BJ
    Am J Med Sci; 2007 Oct; 334(4):317-9. PubMed ID: 18030193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentric Castleman's disease in HIV infection.
    Collins LS; Fowler A; Tong CY; de Ruiter A
    Int J STD AIDS; 2006 Jan; 17(1):19-24; quiz 25. PubMed ID: 16409673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human herpesvirus 8 infections in patients with immunodeficiencies.
    Laurent C; Meggetto F; Brousset P
    Hum Pathol; 2008 Jul; 39(7):983-93. PubMed ID: 18570975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
    Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
    J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma.
    Naresh KN; Rice AJ; Bower M
    Am J Surg Pathol; 2008 Jul; 32(7):1006-12. PubMed ID: 18469709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.